10-K/A

FORM 10-K (AMENDMENT NO. 1)

Company: Vanda Pharmaceuticals Inc.
Filed: June 10, 2015
Period of Report: December 31, 2014
Accession Number: 0001193125-15-219327

View Document ↗ View on SEC.gov ↗